Hearing News Watch

Featured image for “Hearing Aid Intervention Linked to Improved Cognitive Outcomes in Older Adults With MCI”
Sep. 29, 2026

Hearing Aid Intervention Linked to Improved Cognitive Outcomes in Older Adults With MCI

HHTM
A large new clinical trial examining hearing aid use in older adults with both hearing loss and mild cognitive impairment (MCI) has produced an intriguing, though mixed, set of findings. Hearing aids did not significantly reduce the number of participants who progressed to dementia-level impairment over two years—the study’s primary measure. However, participants who received hearing aids were considerably more
Featured image for “Cilcare Opens Japan Subsidiary as Base for Asia-Pacific Expansion”
Sep. 29, 2026

Cilcare Opens Japan Subsidiary as Base for Asia-Pacific Expansion

HHTM
MONTPELLIER, FRANCE & TOKYO, JAPAN — Cilcare has established a new subsidiary in Tokyo as the auditory science-focused biotechnology company expands its presence in Japan and across the broader Asia-Pacific region. The new entity, Cilcare K.K., will serve as a local base for developing partnerships in Japan, connecting Japanese organizations with Cilcare’s international pharmaceutical and biotechnology network, and providing access
Featured image for “VA Emergency Department Tests Hearing Assistive Devices for Veterans”
Sep. 27, 2026

VA Emergency Department Tests Hearing Assistive Devices for Veterans

HHTM
Emergency departments are difficult places to hear. Background conversations, equipment, alarms, and the urgency of care can make it hard for patients to understand questions and instructions. For Veterans with hearing loss, those barriers may affect some of the most consequential conversations of a hospital visit. Researchers at the VA Greater Los Angeles Healthcare System tested a practical response: offering
Featured image for “Researchers Explore Whether Auditory Nerve Cell Therapy Could Improve Cochlear Implant Outcomes”
Sep. 25, 2026

Researchers Explore Whether Auditory Nerve Cell Therapy Could Improve Cochlear Implant Outcomes

HHTM
A cochlear implant can deliver sound information to the inner ear, but its benefit also depends on the auditory nerve carrying that information to the brain. A new review in Hearing Research examines whether cell therapy might one day strengthen that connection for selected patients—and how researchers could identify the people most likely to benefit. The paper, “Boosting auditory nerve
Featured image for “HIA and HLAA Launch “Sounds of America” Hearing Health Campaign”
Sep. 25, 2026

HIA and HLAA Launch “Sounds of America” Hearing Health Campaign

HHTM
The Hearing Industries Association (HIA) and the Hearing Loss Association of America (HLAA) have launched Sounds of America, an eight-week campaign inviting people to share the sounds they associate with home and community. The organizations say the effort is intended to make hearing health conversations more personal and encourage people to seek information and support when they notice a change
Featured image for “Signia Hosts Hearing Care Professionals at COSM Dallas for MaX Launch”
Sep. 23, 2026

Signia Hosts Hearing Care Professionals at COSM Dallas for MaX Launch

HHTM
DALLAS, TEXAS — Signia brought hearing care professionals together at COSM Dallas on September 18 to mark the U.S. launch of its Multi-adaptive Xperience (MaX) hearing aid platform. The event combined product demonstrations, an immersive theater presentation, a neuroscience keynote, and a rooftop drone show. The launch focused on a challenge familiar to hearing care professionals and their patients: following
Featured image for “Neurotone AI Launches Partner Certification for Lace Pro and Tinnitus Pro”
Sep. 22, 2026

Neurotone AI Launches Partner Certification for Lace Pro and Tinnitus Pro

HHTM
GAINESVILLE, FLORIDA — Neurotone AI has launched a new Partner Certification program for hearing care practices and individual providers using its Lace Pro auditory rehabilitation and Tinnitus Pro tinnitus care platforms. The program establishes separate certification pathways for practices and individual clinicians, with the goal of building provider knowledge in aural rehabilitation and tinnitus care while giving participating practices a
Featured image for “Auditdata Appoints Christoffer Spangenberg as CEO”
Sep. 21, 2026

Auditdata Appoints Christoffer Spangenberg as CEO

HHTM
COPENHAGEN, DENMARK — Auditdata has appointed Christoffer Spangenberg as Chief Executive Officer, effective September 25, 2026. Spangenberg will succeed Kurt Bager, who is leaving the company to pursue a new professional chapter. Spangenberg currently serves as Chief Commercial Officer and Head of Delivery at Auditdata and has been with the hearing care software company since 2019. During that time, he
Featured image for “Japanese PEDMARK Study Reports Significant Reduction in Cisplatin-Related Hearing Loss”
Sep. 17, 2026

Japanese PEDMARK Study Reports Significant Reduction in Cisplatin-Related Hearing Loss

HHTM
RESEARCH TRIANGLE PARK, N.C. — New Phase 2 clinical data from Japan found that pediatric and adolescent and young adult (AYA) patients receiving PEDMARK® (sodium thiosulfate) following cisplatin chemotherapy experienced a significantly lower rate of hearing loss compared with a prespecified historical benchmark. Fennec Pharmaceuticals announced detailed results from the investigator-initiated STS-J01 study, which are being presented September 17 at
Featured image for “Amplifon Moves GN Hearing Acquisition Forward with Shareholder Vote on Capital Increase”
Sep. 17, 2026

Amplifon Moves GN Hearing Acquisition Forward with Shareholder Vote on Capital Increase

HHTM
MILAN, ITALY — Amplifon is taking another step toward completing its proposed acquisition of GN Hearing, with the company’s Board of Directors moving to call a shareholders’ meeting to approve the issuance of 56 million new Amplifon shares to GN Store Nord as part of the transaction. The board approved a proposal for a capital increase reserved for GN, which